AU2012284618B2 - Stabilizer, barrier disc and wound dressing comprising stabilizer, method for controlling the position of a wound dressing or barrier disc, and method for facilitating drainage from a wound dressing or barrier disc in negative pressure wound treatment - Google Patents
Stabilizer, barrier disc and wound dressing comprising stabilizer, method for controlling the position of a wound dressing or barrier disc, and method for facilitating drainage from a wound dressing or barrier disc in negative pressure wound treatment Download PDFInfo
- Publication number
- AU2012284618B2 AU2012284618B2 AU2012284618A AU2012284618A AU2012284618B2 AU 2012284618 B2 AU2012284618 B2 AU 2012284618B2 AU 2012284618 A AU2012284618 A AU 2012284618A AU 2012284618 A AU2012284618 A AU 2012284618A AU 2012284618 B2 AU2012284618 B2 AU 2012284618B2
- Authority
- AU
- Australia
- Prior art keywords
- stabilizer
- wound
- barrier disc
- wound dressing
- negative pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010052428 Wound Diseases 0.000 title claims abstract description 367
- 208000027418 Wounds and injury Diseases 0.000 title claims abstract description 363
- 239000003381 stabilizer Substances 0.000 title claims abstract description 274
- 230000004888 barrier function Effects 0.000 title claims abstract description 229
- 238000000034 method Methods 0.000 title claims abstract description 32
- 238000011282 treatment Methods 0.000 title description 27
- 238000009581 negative-pressure wound therapy Methods 0.000 claims abstract description 91
- 230000006641 stabilisation Effects 0.000 claims abstract description 23
- 238000011105 stabilization Methods 0.000 claims abstract description 20
- 210000000056 organ Anatomy 0.000 claims description 14
- 230000026683 transduction Effects 0.000 claims description 14
- 238000010361 transduction Methods 0.000 claims description 14
- 238000012423 maintenance Methods 0.000 abstract description 9
- 239000000463 material Substances 0.000 description 40
- 239000006260 foam Substances 0.000 description 39
- 239000012530 fluid Substances 0.000 description 37
- 210000001519 tissue Anatomy 0.000 description 19
- 239000010410 layer Substances 0.000 description 18
- 201000001231 mediastinitis Diseases 0.000 description 18
- 210000000038 chest Anatomy 0.000 description 14
- 206010048038 Wound infection Diseases 0.000 description 13
- 238000002560 therapeutic procedure Methods 0.000 description 13
- 230000003187 abdominal effect Effects 0.000 description 11
- -1 polyethylene Polymers 0.000 description 11
- 210000001562 sternum Anatomy 0.000 description 11
- 210000001015 abdomen Anatomy 0.000 description 10
- 210000000988 bone and bone Anatomy 0.000 description 10
- 238000007675 cardiac surgery Methods 0.000 description 10
- 239000000835 fiber Substances 0.000 description 8
- 238000001356 surgical procedure Methods 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 230000029663 wound healing Effects 0.000 description 7
- 208000000435 Heart Rupture Diseases 0.000 description 6
- 229920005830 Polyurethane Foam Polymers 0.000 description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000035876 healing Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 239000012188 paraffin wax Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 239000011496 polyurethane foam Substances 0.000 description 6
- 229910052709 silver Inorganic materials 0.000 description 6
- 239000004332 silver Substances 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 229920000058 polyacrylate Polymers 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 238000009958 sewing Methods 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- 238000003466 welding Methods 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 229920000297 Rayon Polymers 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 3
- 239000003570 air Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000002262 irrigation Effects 0.000 description 3
- 238000003973 irrigation Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000004224 pleura Anatomy 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000002861 ventricular Effects 0.000 description 3
- 229920002972 Acrylic fiber Polymers 0.000 description 2
- 206010062542 Arterial insufficiency Diseases 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical group CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 206010031252 Osteomyelitis Diseases 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
- 210000003815 abdominal wall Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008081 blood perfusion Effects 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 235000010410 calcium alginate Nutrition 0.000 description 2
- 239000000648 calcium alginate Substances 0.000 description 2
- 229960002681 calcium alginate Drugs 0.000 description 2
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000006261 foam material Substances 0.000 description 2
- 230000000004 hemodynamic effect Effects 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920006327 polystyrene foam Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 229920006264 polyurethane film Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000010107 reaction injection moulding Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 201000002282 venous insufficiency Diseases 0.000 description 2
- 230000010388 wound contraction Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 208000013875 Heart injury Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010031149 Osteitis Diseases 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000027790 Rib fracture Diseases 0.000 description 1
- 208000036366 Sensation of pressure Diseases 0.000 description 1
- 229920002323 Silicone foam Polymers 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001222723 Sterna Species 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000031650 Surgical Wound Infection Diseases 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- 206010048031 Wound dehiscence Diseases 0.000 description 1
- 101100082060 Xenopus laevis pou5f1.1 gene Proteins 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000004760 aramid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000018339 bone inflammation disease Diseases 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000023753 dehiscence Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000005117 dialkylcarbamoyl group Chemical group 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000001435 haemodynamic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000035990 intercellular signaling Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229920000092 linear low density polyethylene Polymers 0.000 description 1
- 239000004707 linear low-density polyethylene Substances 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005399 mechanical ventilation Methods 0.000 description 1
- 210000001370 mediastinum Anatomy 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000002981 neuropathic effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 229920002493 poly(chlorotrifluoroethylene) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000005023 polychlorotrifluoroethylene (PCTFE) polymer Substances 0.000 description 1
- 229920002721 polycyanoacrylate Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002620 polyvinyl fluoride Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000013514 silicone foam Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000006076 specific stabilizer Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/02—Surgical instruments, devices or methods for holding wounds open, e.g. retractors; Tractors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/915—Constructional details of the pressure distribution manifold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/916—Suction aspects of the dressing specially adapted for deep wounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/917—Suction aspects of the dressing specially adapted for covering whole body parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/92—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with liquid supply means
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Surgery (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SESE1100547-7 | 2011-07-19 | ||
| SE1100547 | 2011-07-19 | ||
| SESE1150912-2 | 2011-10-04 | ||
| SE1150912 | 2011-10-04 | ||
| PCT/SE2012/050804 WO2013012381A1 (en) | 2011-07-19 | 2012-07-06 | Stabilizer, barrier disc and wound dressing comprising stabilizer, method for controlling the position of a wound dressing or barrier disc, and method for facilitating drainage from a wound dressing or barrier disc in negative pressure wound treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2012284618A1 AU2012284618A1 (en) | 2014-01-23 |
| AU2012284618B2 true AU2012284618B2 (en) | 2017-05-18 |
Family
ID=47558354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012284618A Ceased AU2012284618B2 (en) | 2011-07-19 | 2012-07-06 | Stabilizer, barrier disc and wound dressing comprising stabilizer, method for controlling the position of a wound dressing or barrier disc, and method for facilitating drainage from a wound dressing or barrier disc in negative pressure wound treatment |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20150164697A1 (enExample) |
| EP (1) | EP2734260A4 (enExample) |
| JP (1) | JP6258850B2 (enExample) |
| KR (1) | KR20140050658A (enExample) |
| CN (1) | CN103702710B (enExample) |
| AU (1) | AU2012284618B2 (enExample) |
| BR (1) | BR112014001112A2 (enExample) |
| CA (1) | CA2841817A1 (enExample) |
| RU (1) | RU2608238C9 (enExample) |
| WO (1) | WO2013012381A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9820888B2 (en) | 2006-09-26 | 2017-11-21 | Smith & Nephew, Inc. | Wound dressing |
| MX358022B (es) | 2011-02-04 | 2018-08-02 | Univ Massachusetts | Dispositivo para cierre de heridas por presión negativa. |
| US9421132B2 (en) | 2011-02-04 | 2016-08-23 | University Of Massachusetts | Negative pressure wound closure device |
| MX2014014266A (es) | 2012-05-22 | 2015-06-23 | Smith & Nephew | Aparatos y metodos para terapia de heridas. |
| US9844472B2 (en) | 2012-05-22 | 2017-12-19 | Smith & Nephew Plc | Wound closure device |
| CA2874581C (en) | 2012-05-24 | 2022-06-07 | Smith & Nephew Inc. | Devices and methods for treating and closing wounds with negative pressure |
| CN104812343B (zh) | 2012-07-16 | 2019-06-18 | 史密夫和内修有限公司 | 负压伤口闭合设备 |
| DE102013002521A1 (de) | 2013-02-13 | 2014-08-14 | Paul Hartmann Ag | Abdominalwundauflage mit Verbindungsmittel |
| WO2014165275A1 (en) | 2013-03-13 | 2014-10-09 | Smith & Nephew Inc. | Negative pressure wound closure device and systems and methods of use in treating wounds with negative pressure |
| US10159771B2 (en) | 2013-03-14 | 2018-12-25 | Smith & Nephew Plc | Compressible wound fillers and systems and methods of use in treating wounds with negative pressure |
| CN105530898B (zh) | 2013-07-16 | 2020-02-28 | 史密夫及内修公开有限公司 | 用于伤口治疗的设备 |
| CA2926470C (en) * | 2013-10-21 | 2023-03-14 | Smith & Nephew, Inc. | Negative pressure wound closure device |
| EP3096725B1 (en) | 2014-01-21 | 2023-10-18 | Smith & Nephew plc | Wound treatment apparatuses |
| CN110974539A (zh) | 2014-01-21 | 2020-04-10 | 史密夫及内修公开有限公司 | 用于负压伤口治疗的可塌缩敷料 |
| CN104090070B (zh) * | 2014-06-16 | 2015-12-16 | 武汉维斯第医用科技股份有限公司 | 用于医用负压封闭引流材料传导性的测试系统 |
| JP2018519864A (ja) | 2015-04-29 | 2018-07-26 | スミス アンド ネフュー インコーポレイテッド | 陰圧創傷閉鎖デバイス |
| WO2017062257A1 (en) * | 2015-10-07 | 2017-04-13 | Boston Scientific Scimed, Inc. | Method of applying hemostatic or tissue healing agent to wet surfaces |
| US10814049B2 (en) | 2015-12-15 | 2020-10-27 | University Of Massachusetts | Negative pressure wound closure devices and methods |
| US10575991B2 (en) | 2015-12-15 | 2020-03-03 | University Of Massachusetts | Negative pressure wound closure devices and methods |
| US11135351B2 (en) | 2016-08-30 | 2021-10-05 | Smith & Nephew Plc | Systems and methods for applying reduced pressure therapy |
| WO2018060144A1 (en) | 2016-09-27 | 2018-04-05 | Smith & Nephew Plc | Wound closure devices with dissolvable portions |
| CA3042673A1 (en) | 2016-11-02 | 2018-05-11 | Smith & Nephew Inc. | Wound closure devices |
| CN110650755A (zh) * | 2017-03-09 | 2020-01-03 | 生物技术秘书部 | 用于联合的负压和流体输送系统的伤口敷料 |
| US11324876B2 (en) | 2017-06-13 | 2022-05-10 | Smith & Nephew Plc | Collapsible structure and method of use |
| CA3063813A1 (en) | 2017-06-13 | 2018-12-20 | Smith & Nephew Plc | Wound closure device and method of use |
| US11395873B2 (en) | 2017-06-14 | 2022-07-26 | Smith & Nephew, Inc. | Control of wound closure and fluid removal management in wound therapy |
| AU2018284233B2 (en) | 2017-06-14 | 2024-01-04 | Smith & Nephew, Inc. | Fluid removal management and control of wound closure in wound therapy |
| JP7419072B2 (ja) | 2017-06-14 | 2024-01-22 | スミス アンド ネフュー ピーエルシー | 創傷閉鎖のための折り畳み可能シートおよび使用方法 |
| US11583623B2 (en) | 2017-06-14 | 2023-02-21 | Smith & Nephew Plc | Collapsible structure for wound closure and method of use |
| WO2019020544A1 (en) * | 2017-07-27 | 2019-01-31 | Smith & Nephew Plc | CUSTOM WELD CLOSURE DEVICE AND METHOD OF USE |
| WO2019030136A1 (en) | 2017-08-07 | 2019-02-14 | Smith & Nephew Plc | WELD CLOSURE DEVICE WITH PROTECTIVE LAYER AND METHOD OF USE |
| EP3675925B1 (en) | 2017-08-29 | 2025-12-03 | Smith & Nephew PLC | Systems for monitoring wound closure |
| EP3893825A1 (en) | 2018-12-13 | 2021-10-20 | University of Massachusetts | Negative pressure wound closure devices and methods |
| RU2692566C1 (ru) * | 2019-02-05 | 2019-06-25 | Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) | Способ вакуумного дренирования стернотомных ран |
| RU2727577C1 (ru) * | 2019-10-28 | 2020-07-22 | Общество с Ограниченной Ответственностью "ФАРМА - БЬЮТИ" (ООО "ФАРМА - БЬЮТИ") | Устройство для закрытия кожных ран |
| US11160917B2 (en) * | 2020-01-22 | 2021-11-02 | J&M Shuler Medical Inc. | Negative pressure wound therapy barrier |
| CN113679523B (zh) * | 2021-08-12 | 2023-09-05 | 武汉岩硕科技有限公司 | 带有负压创面治疗功能的骨折外固定高分子夹板 |
| CN115463270B (zh) * | 2022-09-13 | 2025-11-07 | 湖北世丰新材料有限公司 | 一种负压引流医用海绵及其制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070260207A1 (en) * | 2006-04-26 | 2007-11-08 | Martin Ugander | Mechanical barrier in wound healing |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU662531B2 (en) * | 1991-06-12 | 1995-09-07 | Mcneil-Ppc, Inc. | Melt blown menstrual pad for application to the body |
| US5636643A (en) * | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
| GB0011202D0 (en) * | 2000-05-09 | 2000-06-28 | Kci Licensing Inc | Abdominal wound dressing |
| ATE387919T1 (de) * | 2001-12-26 | 2008-03-15 | Hill Rom Services Inc | Vakuumbindenverpackung |
| AU2002360757A1 (en) * | 2002-02-28 | 2003-09-16 | Hill-Rom Services, Inc. | External catheter access to vacuum bandage |
| EP1734881A1 (en) * | 2004-04-01 | 2006-12-27 | Synthes GmbH | External fixator for osteosynthesis or bone gap manipulation |
| WO2008004160A2 (en) * | 2006-07-05 | 2008-01-10 | Nicolas Kairinos | Orthopaedic pin isolator |
| KR101567619B1 (ko) * | 2008-05-21 | 2015-11-10 | 모리스 토파즈 | 상처 치료 장치 |
| WO2009142598A1 (en) * | 2008-05-23 | 2009-11-26 | Forskarpatent I Syd Ab | Mechanical barrier disc in wound healing |
| US9943302B2 (en) * | 2008-08-12 | 2018-04-17 | Covidien Lp | Medical device for wound closure and method of use |
| JP5650199B2 (ja) * | 2009-04-10 | 2015-01-07 | スピレイカー・インコーポレイテッドＳｐｉｒａｃｕｒ， Ｉｎｃ． | 閉鎖された切開部用の陰圧閉鎖療法システムを取り付けるための方法および装置 |
| DE102009060596A1 (de) * | 2009-12-23 | 2011-06-30 | Paul Hartmann Aktiengesellschaft, 89522 | Anschlussvorrichtung zur Verwendung bei der Unterdruckbehandlung von Wunden |
| US8500776B2 (en) * | 2010-02-08 | 2013-08-06 | Covidien Lp | Vacuum patch for rapid wound closure |
| US8623047B2 (en) * | 2010-04-30 | 2014-01-07 | Kci Licensing, Inc. | System and method for sealing an incisional wound |
| CN101829391A (zh) * | 2010-05-16 | 2010-09-15 | 崇阳县天南星实业有限责任公司 | 医用引流吸盘及其制备方法 |
| EP2417947A1 (en) * | 2010-08-12 | 2012-02-15 | John Bennett | Integrated contoured negative pressure bandages |
| MX358022B (es) * | 2011-02-04 | 2018-08-02 | Univ Massachusetts | Dispositivo para cierre de heridas por presión negativa. |
-
2012
- 2012-07-06 RU RU2014103186A patent/RU2608238C9/ru not_active IP Right Cessation
- 2012-07-06 AU AU2012284618A patent/AU2012284618B2/en not_active Ceased
- 2012-07-06 JP JP2014521594A patent/JP6258850B2/ja not_active Expired - Fee Related
- 2012-07-06 WO PCT/SE2012/050804 patent/WO2013012381A1/en not_active Ceased
- 2012-07-06 CN CN201280035703.7A patent/CN103702710B/zh not_active Expired - Fee Related
- 2012-07-06 KR KR1020147003466A patent/KR20140050658A/ko not_active Ceased
- 2012-07-06 CA CA2841817A patent/CA2841817A1/en not_active Abandoned
- 2012-07-06 BR BR112014001112A patent/BR112014001112A2/pt not_active IP Right Cessation
- 2012-07-06 US US14/232,473 patent/US20150164697A1/en not_active Abandoned
- 2012-07-06 EP EP12815365.7A patent/EP2734260A4/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070260207A1 (en) * | 2006-04-26 | 2007-11-08 | Martin Ugander | Mechanical barrier in wound healing |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2608238C9 (ru) | 2017-04-17 |
| BR112014001112A2 (pt) | 2019-04-02 |
| CN103702710B (zh) | 2016-06-29 |
| JP2014523784A (ja) | 2014-09-18 |
| AU2012284618A1 (en) | 2014-01-23 |
| KR20140050658A (ko) | 2014-04-29 |
| EP2734260A1 (en) | 2014-05-28 |
| RU2608238C2 (ru) | 2017-01-17 |
| CA2841817A1 (en) | 2013-01-24 |
| CN103702710A (zh) | 2014-04-02 |
| EP2734260A4 (en) | 2015-04-22 |
| JP6258850B2 (ja) | 2018-01-10 |
| RU2014103186A (ru) | 2015-08-27 |
| US20150164697A1 (en) | 2015-06-18 |
| WO2013012381A1 (en) | 2013-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2012284618B2 (en) | Stabilizer, barrier disc and wound dressing comprising stabilizer, method for controlling the position of a wound dressing or barrier disc, and method for facilitating drainage from a wound dressing or barrier disc in negative pressure wound treatment | |
| CA2650318C (en) | Mechanical barrier in wound healing | |
| JP5337248B2 (ja) | 炎症反応の抑制システム及び方法 | |
| JP6285421B2 (ja) | 陰圧により創傷を治療および閉鎖するデバイスおよび方法 | |
| US8415523B2 (en) | Secondary wound dressings for securing primary dressings and managing fluid from wounds, and methods of using same | |
| US7658749B2 (en) | Method for creating a temporary hypobaric wound space in an intentionally left open surgical wound to diagnose substrate losses and prevent exogenous contamination with microorganisms | |
| US20140243762A1 (en) | Systems and methods for wound protection and exudate management | |
| US20080058684A1 (en) | Surgical method | |
| US12485043B2 (en) | Selectively configurable wound dressing | |
| EP3804674B1 (en) | Protective dressing for abdominal viscera in negative pressure therapy | |
| WO2009142598A1 (en) | Mechanical barrier disc in wound healing | |
| US20220125429A1 (en) | Surgical aid device for sutureless closure of skin wound in superficial fascia of skin | |
| US20230024230A1 (en) | Selectively configurable wound dressing | |
| Malmsjö et al. | Effects on heart pumping function when using foam and gauze for negative pressure wound therapy of sternotomy wounds | |
| Marks et al. | Principles and aplications of vacuum-assisted closure (VAC) | |
| US20230026730A1 (en) | Selectively configurable wound dressing | |
| US20170043069A1 (en) | Negative pressure wound therapy removal device | |
| Gisore et al. | Negative pressure wound therapy (NPWT) for the management of laparostomy wounds: case series | |
| WO2023002212A1 (en) | A selectively configurable wound dressing | |
| WO2023002211A1 (en) | A selectively configurable wound dressing | |
| US20170296390A1 (en) | Limb jacket wrap dressing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |